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The eﬀects of stone composition on transurethral lithotripsy (TUL) have not been suﬃciently eluci-
dated.  The purpose of this study was to identify how calcium phosphate stone composition impacts 
TUL.  Two hundred eighty-nine cases of semi-rigid and/or ﬂexible TUL for upper urinary tract calculi 
were reviewed retrospectively.  Inclusion criteria were a preoperative assessment by noncontrast 
computed tomography (NCCT) and a stone composition analysis.  Small stones and those without cal-
cium composition were excluded.  Stone core radiodensity (SCR) was measured by taking the average 
of the upper 3 of 5 points in the proximity of the center of the stone on NCCT.  Fifty-three patients 
with calcium phosphate composition (CaP) and 118 patients with calcium oxalate and without phos-
phate composition were eligible for analysis.  SCR was signiﬁcantly higher in the CaP group (p＜0.01).  
The CaP patient group needed a signiﬁcantly longer operation time (p＝0.014) and more laser energy 
(p＝0.085),  and tended to have a lower rate of complete lithotripsy (p＝0.096) and higher incidence of 
postoperative pyelonephritis (p＝0.181).  Stones containing calcium phosphate are harder,  demand 
more laser energy,  and require a longer operating time.  NCCT evaluation can estimate stone compo-
sition preoperatively,  and may be a useful tool for predicting operative outcomes.
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U rolithiasis is an important health problem that aﬀects all societies.  Approximately 1︲5  of the 
population in Asia experiences urolithiasis ﹇1﹈.  The 
stone size,  chemical composition,  and location can 
inﬂuence the eﬃcacy of medical and surgical treat-
ments for urinary stones.  Transurethral uretero-
scopic lithotripsy (TUL) has been increasingly per-
formed for upper-urinary-tract calculi because of the 
increasing use of thin ureteroscopes,  the preference 
for minimally invasive treatment,  and its higher com-
plete lithotripsy rate.  About 90  of stones are com-
posed of a calcium compound; however,  it is unclear 
whether stone composition aﬀects operative time,  
procedural diﬃculty,  or complications of TUL.  We 
investigated whether stone composition of calcium 
phosphate inﬂuences perioperative outcomes of TUL.
Patients and Methods
　 Patient characteristics. We identiﬁed 289 
operative cases that had undergone semi-rigid and/or 
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ﬂexible TUL for upper urinary calculi from April 
2012 to October 2014.  We recorded various patient 
characteristics,  including age,  sex,  body mass index,  
medical comorbidities,  stone size,  stone location,  
SCR,  stone history,  and stone composition analysis.  
Operation time,  preoperative stent placement,  use of 
access sheath,  use of laser,  amount of laser energy,  
postoperative fever,  and complete lithotripsy were 
obtained from medical reports.  Patients were classi-
ﬁed into two groups according to whether their stones 
contained phosphate or not.  Stone composition was 
analyzed at a reference stone laboratory (SRL Co.  
Ltd.,  Tokyo,  Japan).
　 Study design. A retrospective chart review 
was conducted on all procedures performed for upper 
urinary tract calculi at Abiko Toho Hospital after 
institutional review board approval.  Inclusion criteria 
were patients with a preoperative assessment of non-
contrast computed tomography (NCCT) and a stone 
composition analysis.  Exclusion criteria were stone 
size less than 4mm,  stones without calcium composi-
tion and less than 3 monthsʼ follow-up.  Axial and coro-
nal images of stones were obtained with a helical CT 
using identical settings (120kV,  250mA) for both 5- 
and 3-mm-thick slices.  Stone core radiodensity (SCR) 
was measured by a single urologist taking the average 
of the upper 3 of 5 points in the proximity of the 
center of a stone on NCCT; the region of interest was 
1mm2.  A single anesthesiologist evaluated the 
American Society of Anesthesiologists (ASA) status.  
Complete lithotripsy was deﬁned as complete extrac-
tion of fragments or complete fragmentation into parts 
less than 3mm.
　 Procedural factors. We adopted a non-guide-
wire method for the ureteroscopic procedure ﹇2,  3﹈.  
First,  cystoscopy was done under general anesthesia.  
The ureter was inspected using a 6/7.5Fr dual-chan-
nel semi-rigid ureteroscope (Richard Wolf,  IL,  USA) 
without a guide wire.  Ureteral lithotripsy was per-
formed in situ for patients with ﬁxed ureteral stones.  
Movable ureteral stones were pushed up into the renal 
pelvis.  An initial guidewire was placed to the level of 
inspection.  Special caution was exercised not to 
advance the guidewire into the renal pelvis to avoid 
hemorrhage.  A Flexor 14.4/12Fr ureteral access 
sheath (COOK,  Tokyo,  Japan) was passed over the 
guidewire gently to the level of inspection; then the 
guidewire was removed.  The ﬂexible ureteroscope 
(URF-V,  12Fr,  OLYMPUS,  Tokyo,  Japan) was then 
inserted into the renal pelvis.  After inspecting all 
renal calyces to conﬁrm location,  size,  and number of 
stones,  holmium laser lithotripsy (MM niic,  Tokyo,  
Japan) was started.  Intermittent irrigation was con-
trolled at the lowest pressure manually with a 50-ml 
syringe.  A P︲5 ﬂexible ureteroscope (OLYMPUS,  
Tokyo,  Japan) was used without an access sheath for 
patients with a narrow ureter.  Active fragment 
retrieval using N-CIRCLE (COOK,  Tokyo,  Japan) 
was repeated as long as graspable fragments existed.  
Laser lithotripsy was completed when the fragment 
sizes were all less than 3mm (complete fragmentation) 
or when complete extraction of fragments was attained.  
The maximal lasing time was set at 60min without 
regard to complete lithotripsy.  Prophylactic antibiot-
ics (ceftriaxone) were administered within 2 days to 
patients without urinary tract infection.  A ureteral 
stent was placed after surgery and removed at 2 
weeks.  All data were analyzed using Studentʼs t-test,  
and p values＜0.05 were considered statistically sig-
niﬁcant.
Results
　 Of 289 cases of TUL,  53 patients with calcium 
phosphate composition (CaP group) and 118 cases with 
calcium oxalate but without phosphate composition 
(CaOx group) were eligible for analysis.  Backgrounds 
of patients are listed in Table 1.  In 14 cases,  prior 
shock wave lithotripsy (SWL) had failed.  The per-
centage of females was signiﬁcantly higher in the CaP 
group; however,  age,  body mass index,  ASA score,  
and prevalences of diabetes mellitus,  hypertension,  
hyperlipidemia,  and hyperuricemia were not signiﬁ-
cantly diﬀerent between the 2 groups.  A comparison 
of operative results is shown in Table 2.  Stone size 
and rate of preoperative ureteral stent were not sig-
niﬁcantly diﬀerent; however,  SCR was signiﬁcantly 
higher in the CaP group (p＜0.01).  Patients in the 
CaP group needed signiﬁcantly longer operation time 
(p＜0.05) and more laser energy (p＝0.085).  There 
was a tendency for a lower complete lithotripsy rate 
(p＝0.096) and a higher incidence of postoperative 
pyelonephritis (p＝0.181) in the CaP group.  As a 
surgical complication,  all pyelonephritis cases were 
classiﬁed as Clavien grade 2.  Eighteen and eleven R2 
stones were identiﬁed in the CaOX group and the CaP 
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group,  respectively.  Of them,  failures of complete 
lithotripsy were noted in 4 and 2 cases,  respectively.  
Statistical analysis was diﬃcult to perform due to the 
small sample; however,  no obvious association was 
observed between stone position in calyces and opera-
tive outcome.
　 The percentages of stones with a core attenuation 
＜1,000HU were 50.8  and 34.0  for CaOX and CaP 
stones,  respectively.  Urinary stones with SCR 
＞1,300HU were seen in only 25.4  of patients in the 
CaOX group compared to 43.4  of patients in the CaP 
group.
Discussion
　 Surgical indications for ﬂexible TUL have been 
expanding because recent technological advances have 
enabled thinner ureteroscopes that produce clearer 
images to be manufactured.  Large renal stones such 
as staghorn stones can be treated with TUL instead of 
percutaneous or shock wave lithotripsy.  Due to the 
existence of a clear visual ﬁeld and the adequate 
deﬂection of recent ﬂexible ureteroscopes,  we can 
access almost all calyces to treat stones.  In the cur-
rent study,  no obvious association was observed 
between stone position in calyces and operative out-
comes.  We often experience a stone that is so hard 
that it breaks into pieces during TUL.  SCR on NCCT 
is related to the hardness of calculi; however,  its 
eﬀects on TUL or relation to stone composition have 
not been suﬃciently elucidated.  This is the ﬁrst inves-
tigation to our knowledge of the impact of calculi 
containing calcium phosphate and SCR on the opera-
tive outcome of TUL.
　 Compared to uric acid and cystine stones,  calcium-
containing stones are heterogeneous with higher 
attenuation at the core,  which decreases towards the 
periphery ﹇4﹈.  Torricelli et al.  reported stone core 
and periphery attenuation values; CaOX core 1,099 
(range 635 to 1,522HU) and periphery 514 (range 
304 to 827HU): uric acid core 523 (range 285 to 
759HU) and periphery 382 (244 to 582HU): cystine 
core 648 (257 to 798HU) and periphery 479 (204 to 
776HU) ﹇4﹈.  We recorded 5 points of CT attenua-
tion in the proximity of the center of the stone,  and 
adopted the upper 3 points to reﬂect the hardest area 
of the stone because that portion was sometimes dis-
placed from the center of the stone.
　 Many researchers have attempted to identify stone 
composition preoperatively.  A stone of attenuation 
＜500HU,  ＞4mm in size and urine pH＜5.5 has a 
high predictive value for uric acid composition ﹇5﹈.  
According to our investigation,  the average stone 
attenuation level in the 3 excluded cases of uric acid 
stone was 371.7HU,  and that of one case of struvite 
was 496HU.  Previously reported CT attenuation 
values in uric acid,  struvite,  and cysteine stones are 
approximately 390,  470,  and 510HU,  respectively 
﹇4︲6﹈.  Thus,  it is relatively easy to distinguish these 
3 stones from calcium-containing stones,  whose SCR 
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Table 1　 Background of the patients
CaP CaOX P value
Number of patients 53 118
Age (years) 58.9 61.4 0.349
Rate of female (%) 54.7% 30.5% 0.004
BMI 24.7 24.0 0.424
ASA score 1.83 1.68 0.141
Diabetes mellitus 11.3% 19.5% 0.165
Hypertension 43.4% 35.0% 0.31
Hyperlipidemia 18.9% 10.3% 0.163
Hyperuricemia 3.7% 11.0% 0.067
Stone location
　R2 7 12
　R3 5 11
　U1 23 47
　U2 5 16
　U3 8 26
　Multiple 5 6
BMI,  body mass index; ASA,  American Society of Anesthesiologists.
Table 2　 Comparison of operative results
CaP CaOX P value
Stone size (mm) 10.1 8.7 0.058
(range) 4.2︲24.5 4.4︲41.1
Stone core radiodensity (HU) 1,186 1,034 0.009
(range) 326︲2,028 391︲1,717
Preoperative ureteral stent 37.7% 28.2% 0.232
Operation time (min) 84.9 71.4 0.014
(range) 30︲202 20︲153
Laser energy (kj) 6.12 3.57 0.085
(range) 0.21︲28.8 0.15︲30.2
Complete lithotripsy rate 79.3% 89.8% 0.096
Postoperative pyelonephritis 15.1% 7.6% 0.181
HU,  hounsﬁeld unit.
is＞700HU ﹇4﹈.  Not only the CT attenuation level 
but also the radiolucency on roentgenogram,  past his-
tory,  urine pH,  urine culture,  and blood tests are 
helpful for predicting stone composition before treat-
ment.
　 Our study demonstrated that SCR is signiﬁcantly 
higher in the CaP group.  This suggests that calculi 
containing calcium phosphate are harder than those 
containing calcium oxalate.  The stone size in the CaP 
group (10.1mm) was slightly larger than that in CaOX 
group (8.7mm),  although the diﬀerence was not sig-
niﬁcant (p＝0.058).  The longer operation time in the 
CaP group was probably caused not only by the hard-
ness of the stone,  but also by the size of calculi.  The 
higher laser energy and lower rate of complete litho-
tripsy may also have been inﬂuenced by size.  Ito et al.  
reported that TUL for high stone radiodensity 
demands a longer operative time ﹇7﹈,  which supports 
our results.  Molina et al.  concluded that calcium 
phosphate stones require less laser energy to frag-
ment ﹇8﹈; however,  they only analyzed 22 calcium 
phosphate stones,  giving their conclusions less valid-
ity.  Wiener et al studied the eﬀects of stone composi-
tion on TUL ﹇9﹈; however,  they did not focus on 
phosphate stones due to the small number of samples.  
A higher tendency of postoperative pyelonephritis in 
the CaP group was possibly the result of the larger 
stone burden and longer operating time.  Urologists 
should pay attention when identifying urinary stones 
with a high SCR on NCCT.
　 Interestingly,  the rate of females was signiﬁcantly 
higher in the CaP group.  The reason is unknown,  but 
menopause or changes in the hormonal environment in 
women might be related.  Other preoperative back-
grounds do not explain this sexual speciﬁcity.  No 
relationships between stone composition and lifestyle 
diseases (diabetes,  hypertension,  hyperlipidemia,  
obesity,  and hyperuricemia) were found in this inves-
tigation.
　 A urinary calculus with a core attenuation value 
＞700HU could be considered a calcium-containing 
stone ﹇4︲6,  10﹈.  The hardness of the stone is one of 
the important factors when making a decision on the 
treatment strategy: namely,  selection of TUL or SWL.  
Preliminary NCCT information on a stone is very 
helpful when planning treatments for patients because 
of the likelihood of a poor outcome from SWL when 
the SCR＞970HU ﹇10﹈.  In our series,  stone attenu-
ation levels of 14 TUL patients after SWL failure 
were 1,190HU around the core and 1,066HU on 
average.  Upper urinary stones with SCR＞1,000HU 
can be considered to be an active indication for TUL.  
According to our results,  the percentages of stones 
with a core attenuation＜1,000HU are 50.8  and 
34.0  for CaOX and CaP stones,  respectively.  A 
urinary stone with SCR＞1,300HU was seen only in 
25.4  of the CaOX group; however,  it was seen in 
43.4  of patients in the CaP group.  Thus,  a urinary 
stone with a higher CT attenuation level has a higher 
probability of having a phosphate composition.  
Furthermore,  stones with TUL in patients whose CT 
attenuation level was＞1,300HU seemed very diﬃcult 
to treat.  We suggest that urinary stones with SCR 
＞1,300HU have a relatively high probability of being 
a CaP stone and require extra caution during TUL.
　 The limitations of this study include its being a 
retrospective,  single-center investigation,  and the 
small number of stones examined.  The phosphate 
composition might have been overlooked in some cases 
because not all fragments were collected at the time of 
surgery.  Operation time indicates overall operative 
time; it does not necessarily represent lasing time.  
The stones examined in the study cohort numbered no 
more than 170; however,  this study found a signiﬁ-
cantly higher SCR in stones containing calcium phos-
phate,  and thus our study has a certain level of reli-
ability.
　 In conclusion,  stones containing calcium phosphate 
are harder,  demand more laser energy,  and require a 
longer operating time.  NCCT evaluation can estimate 
stone composition preoperatively,  and may be a useful 
tool for predicting operative outcomes.  Calcium 
phosphate-containing stones were more often seen in 
females.
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